|
Volumn 22, Issue 11, 2014, Pages 2919-2938
|
Identification of trisubstituted-pyrazol carboxamide analogs as novel and potent antagonists of farnesoid X receptor
|
Author keywords
Abbreviations; BAs; bile acids; bile salt export pump; BSEP; Cyp7A1; cytochrome 7A1; farnesoid X receptor; FXR; high throughput screen; HTS; LBD; ligand binding domain; NRs; nuclear receptors; SAR; structure activity relationship
|
Indexed keywords
1 (2,3 DIHYDRO 1H INDEN 1 YL) 3 (PARA TOLYL) 1H PYRAZOLE 4 CARBALDEHYDE;
1 (2,4 DICHLOROPHENYL) 2 (1 PARA TOLYLETHYLIDENE)HYDRAZINE;
1 (2,4 DICHLOROPHENYL) 3 PARA TOLYL 1H PYRAZOLE 4 CARBALDEHYDE;
1 (2,4 DICHLOROPHENYL) 3 PARA TOLYL 1H PYRAZOLE 4 CARBOXYLIC ACID;
1 (2,4 DICHLOROPHENYL) N [4 METHYL 3 (MORPHOLINOSULFONYL)PHENYL] 3 (PARA TOLYL) 1H PYRAZOLE 4 CARBOXAMIDE;
1 (3 CHLOROPHENYL) 2 (1 PARA TOLYLETHYLIDENE)HYDRAZINE;
1 (3 CHLOROPHENYL) 3 PARA TOLYL 1H PYRAZOLE 4 CARBALDEHYDE;
1 (3 CHLOROPHENYL) 3 PARA TOLYL 1H PYRAZOLE 4 CARBOXYLIC ACID;
1 (3 CHLOROPHENYL) N [4 METHYL 3 (MORPHOLINOSULFONYL)PHENYL] 3 (PARA TOLYL) 1H PYRAZOLE 4 CARBOXAMIDE;
1 (3 METHOXYBENZYL) 3 (3 METHOXYPHENYL) N [4 METHYL 3 (MORPHOLINOSULFONYL)PHENYL] 1H PYRAZOLE 4 CARBOXAMIDE;
1 (3 TRIFLUROMETHYLPHENYL) 2 (1 PARA TOLYLETHYLIDENE)HYDRAZINE;
1 (4 FLUOROPHENYL) 2 (1 PARA TOLYLETHYLIDENE)HYDRAZINE;
1 (4 FLUOROPHENYL) 3 PARA TOLYL 1H PYRAZOLE 4 CARBALDEHYDE;
1 (4 FLUOROPHENYL) 3 PARA TOLYL 1H PYRAZOLE 4 CARBOXYLIC ACID;
1 (4 FLUOROPHENYL) N [4 METHYL 3 (MORPHOLINOSULFONYL)PHENYL] 3 PARA TOLYL 1H PYRAZOLE 4 CARBOXAMIDE;
1 (BENZO[D]THIAZOL 2 YL) N [4 METHYL 3 (MORPHOLINOSULFONYL)PHENYL] 3 (PARA TOLYL) 1H PYRAZOLE 4 CARBOXAMIDE;
1 BUTYL N [4 METHYL 3 (MORPHOLINOSULFONYL)PHENYL] 3 (PARA TOLYL) 1H PYRAZOLE 4 CARBOXAMIDE;
1 ISOPROPYL N [4 METHYL 3 (MORPHOLINOSULFONYL)PHENYL] 3 (PARA TOLYL) 1H PYRAZOLE 4 CARBOXAMIDE;
2 [2 [1 (PARA TOLYL)ETHYLIDENE]HYDRAZINYL]BENZO[D]THIAZOLE;
3 (PARA TOLYL) 1 (3 (TRIFLUOROMETHYL)PHENYL) 1H PYRAZOLE 4 CARBOXYLIC ACID;
3 PARA TOLYL 1 [3 (TRIFLUOROMETHYL)PHENYL] 1H PYRAZOLE 4 CARBALDEHYDE;
AMIDE;
CARBOXYLIC ACID;
CHEMICAL COMPOUND;
FARNESOID X RECEPTOR;
HORMONE RECEPTOR BLOCKING AGENT;
HYDRAZINE;
N [4 METHYL 3 (MORPHOLINOSULFONYL)PHENYL] 3 (PARA TOLYL) 1 [3 (TRIFLUOROMETHYL) PHENYL] 1H PYRAZOLE 4 CARBOXAMIDE;
THIAZOLE;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
CELL RECEPTOR;
FARNESOID X-ACTIVATED RECEPTOR;
PYRAZOLE DERIVATIVE;
ARTICLE;
BINDING AFFINITY;
CONCENTRATION RESPONSE;
CONTROLLED STUDY;
CYTOTOXICITY ASSAY;
DRUG IDENTIFICATION;
DRUG RECEPTOR BINDING;
DRUG SCREENING;
DRUG SYNTHESIS;
DRUG TOXICITY;
FLUORESCENCE RESONANCE ENERGY TRANSFER;
IC 50;
PHYSICAL CHEMISTRY;
PROTEIN BINDING;
RECEPTOR BINDING ASSAY;
STRUCTURE ACTIVITY RELATION;
TRANSACTIVATION ASSAY;
ANTAGONISTS AND INHIBITORS;
CHEMICAL STRUCTURE;
CHEMISTRY;
DOSE RESPONSE;
HEK293 CELL LINE;
HUMAN;
SYNTHESIS;
AMIDES;
DOSE-RESPONSE RELATIONSHIP, DRUG;
HEK293 CELLS;
HUMANS;
MOLECULAR STRUCTURE;
PYRAZOLES;
RECEPTORS, CYTOPLASMIC AND NUCLEAR;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 84899938747
PISSN: 09680896
EISSN: 14643391
Source Type: Journal
DOI: 10.1016/j.bmc.2014.04.014 Document Type: Article |
Times cited : (33)
|
References (38)
|